Healthy Clinical Trial
Official title:
A Study to Determine the Acute Effects of a Tea Component on Blood Pressure and Mental Stress Challenge
Verified date | December 2015 |
Source | Unilever R&D |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Interventional |
Assess the effects of adding theanine to a caffeinated beverage on changes in blood pressure during acute mental stress.
Status | Completed |
Enrollment | 56 |
Est. completion date | November 2015 |
Est. primary completion date | October 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Apparently healthy males and females - Women taking the contraceptive pill - 18-45 years of age - BMI 20-30 kg/m2 - Normal or corrected vision - Low caffeine consumers (<100mg/day) - Non smokers and having been a non-smoker for > 6 months - Fluent English - Normotensive (>90/60 <140/90 mmHg) Exclusion Criteria: - Significant current or medical history of cardiovascular disease - Low or high STAI trait score in the opinion of the PI - Known sensitivity to caffeine or theanine - Colour blindness - Alcohol consumption above 14/21 units female/male resp. per week - Weight loss diet > 10% of bodyweight in the previous year - Anyone with a dependency on PI or staff of Department of Epidemiology and Public Health or being an employee of Unilever - Reported participation in another biomedical study < 3 months before screening |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United Kingdom | University College London | London |
Lead Sponsor | Collaborator |
---|---|
Unilever R&D | University College, London |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cortisol in saliva before and immediately after stress | Concentration of cortisol in saliva | -5, 45 min relative to test product intake | No |
Other | Heart rate during stress | Heart rate during acute mental stress | Between 30-45 minutes after test product intake | No |
Other | Heart rate after stress | Heart rate immediately after acute mental stress | Between 45-60 minutes after test product intake | No |
Other | Heart rate variability during stress | Heart rate variability during acute mental stress | Between 30-45 minutes after test product intake | No |
Other | Heart rate variability after stress | Heart rate variability immediately after acute mental stress | Between 45-60 minutes after test product intake | No |
Other | Performance STROOP | Task performance on STROOP task | Between 30-45 minutes after test product intake | No |
Other | Performance mirror tracing | Task performance on mirror tracing task | Between 30-45 minutes after test product intake | No |
Other | Systolic blood pressure, free living phase | Ambulatory systolic blood pressure during free living phase | Between 80-270 minutes after test product intake | No |
Other | Diastolic blood pressure, free living phase | Ambulatory diastolic blood pressure during free living phase | Between 80-270 minutes after test product intake | No |
Other | Cortisol, free living phase | Concentration of cortisol in saliva during free living phase | 140, 200 and 260 minutes after test product intake | No |
Other | STAI, free living phase | Self-reported mental state: State-Trait Anxiety Inventory during free living phase | 140, 200 and 260 minutes after test product intake | No |
Other | UWIST, free living phase | Self-reported mental state: University Of Wales Institute of Science and Technology) mood adjective questionnaire during free living phase | 140, 200 and 260 minutes after test product intake | No |
Other | Pulse pressure during stress | Mean pulse pressure during mental stress | Between 30-45 minutes after test product intake | No |
Other | Pulse pressure after stress | Mean pulse pressure after acute mental stress | Between 45-60 minutes after test product intake | No |
Other | Mental wellbeing | Mental well being as assessed by on line survey an each evening during the 7 day period the accelerometer is worn. | 7 consecutive days prior to the lab sessions | No |
Other | Physical activity | Habitual patterns in physical activity as measured by accelerometer | 7 consecutive days prior to the lab sessions | No |
Other | STAI screening | State-Trait Anxiety Inventory (STAI) - Trait version, covariate | Screening | No |
Other | CES-D | Center for Epidemiologic Studies Depression scale, covariate | Screening | No |
Other | CISS | CISS coping scale, covariate | Screening | No |
Other | loneliness | UCLA loneliness scale, covariate | Screening | No |
Other | Perceived stress | Perceived Stress Scale, covariate | Screening | No |
Primary | Systolic blood pressure during stress | Systolic blood pressure during acute mental stress | Between 30-45 minutes after test product intake | No |
Secondary | Diastolic blood pressure during stress | Diastolic blood pressure during acute mental stress | Between 30-45 minutes after test product intake | No |
Secondary | Systolic blood pressure after stress | Systolic blood pressure immediately after acute mental stress | Between 45-60 minutes after test product intake | No |
Secondary | Diastolic blood pressure after stress | Diastolic blood pressure immediately after acute mental stress | Between 45-60 minutes after test product intake | No |
Secondary | STAI before and immediately after stress | Self-reported mental state: State-Trait Anxiety Inventory | -15 and 45 relative to test product intake | No |
Secondary | UWIST before and immediately after stress | Self-reported mental state: University Of Wales Institute of Science and Technology mood adjective questionnaire | -10, 45 minutes relative to test product intake | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |